BerandaBAVA • VIE
add
Bavarian Nordic A/S
Tutup sebelumnya
€21,86
Rentang hari
€22,08 - €22,48
Rentang tahun
€17,92 - €39,43
Kapitalisasi pasar
1,96 M USD
Volume Rata-Rata
54,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
CPH
Berita pasar
Vibiznews.com
1 hari yang lalu
Wall Street Lanjut Mixed dengan S&P 500 Naik ke Tertinggi 2 Bulan Lebih
0,70%
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (DKK) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 1,35 M | 61,95% |
Biaya operasional | 421,76 jt | 7,01% |
Laba bersih | 218,76 jt | 291,14% |
Margin laba bersih | 16,25 | 218,10% |
Penghasilan per saham | — | — |
EBITDA | 419,55 jt | 1.821,18% |
Tarif pajak efektif | 4,70% | — |
Neraca
Total aset
Total liabilitas
| (DKK) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,24 M | -46,10% |
Total aset | 13,55 M | -0,50% |
Total liabilitas | 2,00 M | -42,07% |
Total ekuitas | 11,56 M | — |
Saham yang beredar | 77,84 jt | — |
Harga terhadap nilai buku | 0,15 | — |
Tingkat pengembalian aset | 4,63% | — |
Tingkat pengembalian modal | 5,58% | — |
Arus Kas
Perubahan kas bersih
| (DKK) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 218,76 jt | 291,14% |
Kas dari operasi | -387,05 jt | -188,93% |
Kas dari investasi | -373,18 jt | 64,29% |
Kas dari pembiayaan | -160,99 jt | -1.400,76% |
Perubahan kas bersih | -931,98 jt | -51,19% |
Arus kas bebas | -1,24 M | -199,38% |
Tentang
Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany and San Diego, California, as well as offices in Zug, Switzerland, and Morrisville, North Carolina. The company uses viral vectors and virus-like particles in its research and development. Wikipedia
CEO
Didirikan
1 Jul 1992
Situs
Karyawan
1.645
